Tyler Stone Wealth Management Invitae Corp Transaction History

Tyler Stone Wealth Management

  • $237 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.42 - $0.72 $5,334 - $9,144
12,700 Added 108.18%
24,440 $15,000
Q3 2023

Nov 14, 2023
BUY
$0.6 - $1.53 $1,800 - $4,590
3,000 Added 34.32%
11,740 $7,000
Q2 2023

Aug 14, 2023
BUY
$1.05 - $1.63 $3,675 - $5,705
3,500 Added 66.79%
8,740 $10,000
Q2 2022

Aug 11, 2022
BUY
$2.13 - $9.01 $5,325 - $22,525
2,500 Added 91.24%
5,240 $13,000
Q4 2021

Feb 22, 2022
BUY
$14.7 - $28.67 $40,278 - $78,555
2,740 New
2,740 $42,000

Others Institutions Holding NVTA

# of Institutions
38
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Tyler Stone Wealth Management Portfolio

Follow Tyler Stone Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyler Stone Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Tyler Stone Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email